Xiaflex collagenase clostridium histolyticum: Phase III started

Last month, Auxilium began the 36-week, open-label, international Phase III Impress trial in >=250 patients to evaluate twice-weekly Xiaflex every 6 weeks for up to 4 treatment cycles followed by a pe...